Cancer Research Donn Young  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1063-1067, March 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watkins, P. J.
Right arrow Articles by Adams, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watkins, P. J.
Right arrow Articles by Adams, D. J.

Impaired Proliferation and Tumorigenicity Induced by CCAAT/Enhancer-binding Protein

Pamela J. Watkins1, J. Patrick Condreay, Brian E. Huber, Steven J. Jacobs and David J. Adams

Division of Cell Biology, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709

A plasmid containing the CCAAT/enhancer-binding protein (C/EBP{alpha}) gene transcriptionally controlled by the metallothionein promoter was constructed. The gene was transfected into the human hepatocellular carcinoma cell lines Hep3B and HepG2. When cultured in vitro in the presence of 100 µM ZnSO4, C/EBP{alpha} expression caused reversible growth arrest. In soft agar clonogenic assays, C/EBP{alpha} expression decreased both the colony size and the total number of colonies compared with zinc-free controls. C/EBP{alpha} expressing cells s.c. implanted in Cd-1 nu/nu mice were essentially nontumorigenic, whereas C/EBP{alpha} tumor cells implanted into immunodeficient SCID mice demonstrated a significantly delayed time of tumor appearance compared with cells transfected with a vector control plasmid. These studies suggest that the expression of endogenous genes normally associated with a quiescent, differentiated state, such as C/EBP{alpha}, can result in impaired proliferative activity and suppressed tumorigenicity of hepatoma cell lines.

1 To whom reprint requests should be addressed, at Division of Cell Biology, Wellcome Research Laboratories, 3030 Cornwallis Road, Research Triangle Park, NC 27709. Phone: (919)-483-1262; Fax: (919)-315-3321.

Received 6/27/95. Accepted 1/ 2/96.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Pabst and B. U. Mueller
Complexity of CEBPA Dysregulation in Human Acute Myeloid Leukemia
Clin. Cancer Res., September 1, 2009; 15(17): 5303 - 5307.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Koschmieder, B. Halmos, E. Levantini, and D. G. Tenen
Dysregulation of the C/EBP{alpha} Differentiation Pathway in Human Cancer
J. Clin. Oncol., February 1, 2009; 27(4): 619 - 628.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. D. Loomis, S. Zhu, K. Yoon, P. F. Johnson, and R. C. Smart
Genetic Ablation of CCAAT/Enhancer Binding Protein {alpha} in Epidermis Reveals Its Role in Suppression of Epithelial Tumorigenesis
Cancer Res., July 15, 2007; 67(14): 6768 - 6776.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Parent, D. Kolippakkam, G. Booth, and L. Beretta
Mammalian Target of Rapamycin Activation Impairs Hepatocytic Differentiation and Targets Genes Moderating Lipid Homeostasis and Hepatocellular Growth
Cancer Res., May 1, 2007; 67(9): 4337 - 4345.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yin and J. Glass
In Prostate Cancer Cells the Interaction of C/EBP{alpha} with Ku70, Ku80, and Poly(ADP-ribose) Polymerase-1 Increases Sensitivity to DNA Damage
J. Biol. Chem., April 28, 2006; 281(17): 11496 - 11505.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
Y. Tada, R. M. Brena, B. Hackanson, C. Morrison, G. A. Otterson, and C. Plass
Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
J Natl Cancer Inst, March 15, 2006; 98(6): 396 - 406.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Shim, K. L. Powers, S. J. Ewing, S. Zhu, and R. C. Smart
Diminished Expression of C/EBP{alpha} in Skin Carcinomas Is Linked to Oncogenic Ras and Reexpression of C/EBP{alpha} in Carcinoma Cells Inhibits Proliferation
Cancer Res., February 1, 2005; 65(3): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Halmos, D. S. Basseres, S. Monti, F. D'Alo, T. Dayaram, K. Ferenczi, B. J. Wouters, C. S. Huettner, T. R. Golub, and D. G. Tenen
A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3{beta} as a Novel Tumor Suppressor in Lung Cancer
Cancer Res., June 15, 2004; 64(12): 4137 - 4147.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. D'Alo', L. M. Johansen, E. A. Nelson, H. S. Radomska, E. K. Evans, P. Zhang, C. Nerlov, and D. G. Tenen
The amino terminal and E2F interaction domains are critical for C/EBP{alpha}-mediated induction of granulopoietic development of hematopoietic cells
Blood, November 1, 2003; 102(9): 3163 - 3171.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. D. Bjerregaard, J. Jurlander, P. Klausen, N. Borregaard, and J. B. Cowland
The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow
Blood, June 1, 2003; 101(11): 4322 - 4332.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Iwama, M. Osawa, R. Hirasawa, N. Uchiyama, S. Kaneko, M. Onodera, K. Shibuya, A. Shibuya, C. Vinson, D. G. Tenen, et al.
Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment
J. Exp. Med., February 25, 2002; 195(5): 547 - 558.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. F. Gombart, W.-K. Hofmann, S. Kawano, S. Takeuchi, U. Krug, S. H. Kwok, R. J. Larsen, H. Asou, C. W. Miller, D. Hoelzer, et al.
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias
Blood, February 15, 2002; 99(4): 1332 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Halmos, C. S. Huettner, O. Kocher, K. Ferenczi, D. D. Karp, and D. G. Tenen
Down-Regulation and Antiproliferative Role of C/EBP{alpha} in Lung Cancer
Cancer Res., January 1, 2002; 62(2): 528 - 534.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. M. Johansen, A. Iwama, T. A. Lodie, K. Sasaki, D. W. Felsher, T. R. Golub, and D. G. Tenen
c-Myc Is a Critical Target for C/EBP{alpha} in Granulopoiesis
Mol. Cell. Biol., June 1, 2001; 21(11): 3789 - 3806.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. Xu, L. Hui, S. Wang, J. Gong, Y. Jin, Y. Wang, Y. Ji, X. Wu, Z. Han, and G. Hu
Expression Profiling Suggested a Regulatory Role of Liver-enriched Transcription Factors in Human Hepatocellular Carcinoma
Cancer Res., April 1, 2001; 61(7): 3176 - 3181.
[Abstract] [Full Text]


Home page
BloodHome page
P. Zhang, X. Zhang, A. Iwama, C. Yu, K. A. Smith, B. U. Mueller, S. Narravula, B. E. Torbett, S. H. Orkin, and D. G. Tenen
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Blood, October 15, 2000; 96(8): 2641 - 2648.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. A. Slomiany, K. L. D'Arigo, M. M. Kelly, and D. T. Kurtz
C/EBPalpha Inhibits Cell Growth via Direct Repression of E2F-DP-Mediated Transcription
Mol. Cell. Biol., August 15, 2000; 20(16): 5986 - 5997.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Kubicka, F. Kuhnel, L. Zender, K. L. Rudolph, J. Plumpe, M. Manns, and C. Trautwein
p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin Gene. A MOLECULAR MECHANISM INVOLVED IN VIRAL LIVER INFECTION WITH IMPLICATIONS FOR HEPATOCARCINOGENESIS
J. Biol. Chem., November 5, 1999; 274(45): 32137 - 32144.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. A. Ramos, W. J. Meilandt, E. C. Wang, and G. L. Firestone
Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant
FASEB J, January 1, 1999; 13(1): 169 - 180.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. M. Diehl
Roles of CCAAT/Enhancer-binding Proteins in Regulation of Liver Regenerative Growth
J. Biol. Chem., November 20, 1998; 273(47): 30843 - 30846.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kim and S. M. Fischer
Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells. REGULATORY ROLE OF CCAAT/ENHANCER-BINDING PROTEINS IN THE DIFFERENTIAL EXPRESSION OF CYCLOOXYGENASE-2 IN NORMAL AND NEOPLASTIC TISSUES
J. Biol. Chem., October 16, 1998; 273(42): 27686 - 27694.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. S. Radomska, C. S. Huettner, P. Zhang, T. Cheng, D. T. Scadden, and D. G. Tenen
CCAAT/Enhancer Binding Protein alpha  Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors
Mol. Cell. Biol., July 1, 1998; 18(7): 4301 - 4314.
[Abstract] [Full Text]


Home page
BloodHome page
D. G. Tenen, R. Hromas, J. D. Licht, and D.-E. Zhang
Transcription Factors, Normal Myeloid Development, and Leukemia
Blood, July 15, 1997; 90(2): 489 - 519.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.